Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori–Associated Ulcer Disease

Raja Singh Paulraj,1 Parthasarathi Perumal,2 Arunkumar Ramachandran,3 Anbazhagan Sathiyaseelan4 1Robert C. Byrd Biotechnology Science Center, Marshall University, Huntington, WV, USA; 2Department of Molecular and Cell Biology, Greensmed Labs, Chennai, TN, India; 3Multidisciplinary Research Unit, a Unit of DHR ICMR, Madras Medical College, Chennai, TN, India; 4Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of KoreaCorrespondence: Raja Singh Paulraj, Email [email protected] Anbazhagan Sathiyaseelan, Email [email protected]: Gastric ulcer disease remains a significant global health concern, with Helicobacter pylori (H. pylori) infection being a primary etiological factor. Conventional therapies are increasingly limited by antibiotic resistance, treatment failure, and adverse effects. In this context, phytomedicine has emerged as a promising complementary and alternative therapeutic approach. This review systematically discusses the key mechanisms by which phytomedicines enhance gastric mucosal defense, including antioxidant activity, anti-inflammatory modulation, inhibition of urease and bacterial adhesion, suppression of virulence factors, and restoration of epithelial barrier integrity. Plant-derived bioactive compounds demonstrate multi-targeted gastroprotective effects through modulation of oxidative stress, cytokine signaling, prostaglandin synthesis, and tight junction preservation. While preclinical and limited clinical evidence support their therapeutic potential, further well-designed clinical trials and standardized phytochemical formulations are required to validate translational applicability.Keywords: antioxidant, gastric ulcer, H. pylori, inflammation, phytomedicine

Authors

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2026-04-14
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori–Associated Ulcer Disease

Anbazhagan Sathiyaseelan, Parthasarathi Perumal, A Ramachandran, Raja Singh Paulraj
Dove Medical Press (Taylor and Francis Group)
Helicobacter pylori-related gastroenterology studies
article

Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori–Associated Ulcer Disease

Anbazhagan Sathiyaseelan, Parthasarathi Perumal, A Ramachandran, Raja Singh Paulraj
article en

Abstract

Raja Singh Paulraj,1 Parthasarathi Perumal,2 Arunkumar Ramachandran,3 Anbazhagan Sathiyaseelan4 1Robert C. Byrd Biotechnology Science Center, Marshall University, Huntington, WV, USA; 2Department of Molecular and Cell Biology, Greensmed Labs, Chennai, TN, India; 3Multidisciplinary Research Unit, a Unit of DHR ICMR, Madras Medical College, Chennai, TN, India; 4Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of KoreaCorrespondence: Raja Singh Paulraj, Email [email protected] Anbazhagan Sathiyaseelan, Email [email protected]: Gastric ulcer disease remains a significant global health concern, with Helicobacter pylori (H. pylori) infection being a primary etiological factor. Conventional therapies are increasingly limited by antibiotic resistance, treatment failure, and adverse effects. In this context, phytomedicine has emerged as a promising complementary and alternative therapeutic approach. This review systematically discusses the key mechanisms by which phytomedicines enhance gastric mucosal defense, including antioxidant activity, anti-inflammatory modulation, inhibition of urease and bacterial adhesion, suppression of virulence factors, and restoration of epithelial barrier integrity. Plant-derived bioactive compounds demonstrate multi-targeted gastroprotective effects through modulation of oxidative stress, cytokine signaling, prostaglandin synthesis, and tight junction preservation. While preclinical and limited clinical evidence support their therapeutic potential, further well-designed clinical trials and standardized phytochemical formulations are required to validate translational applicability.Keywords: antioxidant, gastric ulcer, H. pylori, inflammation, phytomedicine

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 19%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.